Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Takeda’s $75 Million Investment in Ascentage Pharma
Ascentage Pharma’s Strategic Collaboration with Innovent Biologics
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...
Ascentage Pharma’s Strategic Collaboration with Innovent Biologics
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...